150 related articles for article (PubMed ID: 34043239)
1. A new D-galactose treatment monitoring index for PGM1-CDG.
Perales-Clemente E; Liedtke K; Studinski A; Radenkovic S; Gavrilov D; Oglesbee D; Matern D; Rinaldo P; Tortorelli S; Morava E; Raymond K
J Inherit Metab Dis; 2021 Sep; 44(5):1263-1271. PubMed ID: 34043239
[TBL] [Abstract][Full Text] [Related]
2. Oral D-galactose supplementation in PGM1-CDG.
Wong SY; Gadomski T; van Scherpenzeel M; Honzik T; Hansikova H; Holmefjord KSB; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Hertecant J; Preston G; Jaeken J; Peeters N; Perez S; Nguyen DD; Crivelly K; Emmerzaal T; Gibson KM; Raymond K; Abu Bakar N; Foulquier F; Poschet G; Ackermann AM; He M; Lefeber DJ; Thiel C; Kozicz T; Morava E
Genet Med; 2017 Nov; 19(11):1226-1235. PubMed ID: 28617415
[TBL] [Abstract][Full Text] [Related]
3. Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.
Abu Bakar N; Voermans NC; Marquardt T; Thiel C; Janssen MCH; Hansikova H; Crushell E; Sykut-Cegielska J; Bowling F; MØrkrid L; Vissing J; Morava E; van Scherpenzeel M; Lefeber DJ
Transl Res; 2018 Sep; 199():62-76. PubMed ID: 30048639
[TBL] [Abstract][Full Text] [Related]
4. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.
Altassan R; Radenkovic S; Edmondson AC; Barone R; Brasil S; Cechova A; Coman D; Donoghue S; Falkenstein K; Ferreira V; Ferreira C; Fiumara A; Francisco R; Freeze H; Grunewald S; Honzik T; Jaeken J; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-da-Silva D; Pascoal C; Quelhas D; Raymond KM; Rymen D; Seroczynska M; Serrano M; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Voermans N; Witters P; Morava E
J Inherit Metab Dis; 2021 Jan; 44(1):148-163. PubMed ID: 32681750
[TBL] [Abstract][Full Text] [Related]
5. Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.
Morava E
Mol Genet Metab; 2014 Aug; 112(4):275-9. PubMed ID: 24997537
[TBL] [Abstract][Full Text] [Related]
6. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.
Radenkovic S; Bird MJ; Emmerzaal TL; Wong SY; Felgueira C; Stiers KM; Sabbagh L; Himmelreich N; Poschet G; Windmolders P; Verheijen J; Witters P; Altassan R; Honzik T; Eminoglu TF; James PM; Edmondson AC; Hertecant J; Kozicz T; Thiel C; Vermeersch P; Cassiman D; Beamer L; Morava E; Ghesquière B
Am J Hum Genet; 2019 May; 104(5):835-846. PubMed ID: 30982613
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series.
Radenkovic S; Johnsen C; Schulze A; Lail G; Guilder L; Schwartz K; Schultz M; Mercimek-Andrews S; Boyer S; Morava E
Ther Adv Rare Dis; 2023; 4():26330040221150269. PubMed ID: 37181075
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
[TBL] [Abstract][Full Text] [Related]
9. Limitations of galactose therapy in phosphoglucomutase 1 deficiency.
Nolting K; Park JH; Tegtmeyer LC; Zühlsdorf A; Grüneberg M; Rust S; Reunert J; Du Chesne I; Debus V; Schulze-Bahr E; Baxter RC; Wada Y; Thiel C; van Schaftingen E; Fingerhut R; Marquardt T
Mol Genet Metab Rep; 2017 Dec; 13():33-40. PubMed ID: 28794993
[TBL] [Abstract][Full Text] [Related]
10. Coagulation abnormalities and vascular complications are common in PGM1-CDG.
Radenkovic S; Bleukx S; Engelhardt N; Eklund E; Mercimek-Andrews S; Edmondson AC; Morava E
Mol Genet Metab; 2024 Jul; 142(4):108530. PubMed ID: 38968673
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Skeletal Muscle Model of PGM1 Deficiency Reveals Altered Energy Homeostasis.
Conte F; Ashikov A; Mijdam R; van de Ven EGP; van Scherpenzeel M; Veizaj R; Mahalleh-Yousefi SP; Post MA; Huijben K; Panneman DM; Rodenburg RJT; Voermans NC; Garanto A; Koopman WJH; Wessels HJCT; Noga MJ; Lefeber DJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175952
[TBL] [Abstract][Full Text] [Related]
12. PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.
Voermans NC; Preisler N; Madsen KL; Janssen MC; Kusters B; Abu Bakar N; Conte F; Lamberti VM; Nusman F; van Engelen BG; van Scherpenzeel M; Vissing J; Lefeber DJ
Neuromuscul Disord; 2017 Apr; 27(4):370-376. PubMed ID: 28190645
[TBL] [Abstract][Full Text] [Related]
13. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.
Pérez B; Medrano C; Ecay MJ; Ruiz-Sala P; Martínez-Pardo M; Ugarte M; Pérez-Cerdá C
J Inherit Metab Dis; 2013 May; 36(3):535-42. PubMed ID: 22976764
[TBL] [Abstract][Full Text] [Related]
14. PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure.
Zeevaert R; Scalais E; Muino Mosquera L; De Meirleir L; De Beaufort C; Witsch M; Jaeken J; De Schepper J
Acta Clin Belg; 2016 Dec; 71(6):435-437. PubMed ID: 27351072
[TBL] [Abstract][Full Text] [Related]
15. Multiple phenotypes in phosphoglucomutase 1 deficiency.
Tegtmeyer LC; Rust S; van Scherpenzeel M; Ng BG; Losfeld ME; Timal S; Raymond K; He P; Ichikawa M; Veltman J; Huijben K; Shin YS; Sharma V; Adamowicz M; Lammens M; Reunert J; Witten A; Schrapers E; Matthijs G; Jaeken J; Rymen D; Stojkovic T; Laforêt P; Petit F; Aumaître O; Czarnowska E; Piraud M; Podskarbi T; Stanley CA; Matalon R; Burda P; Seyyedi S; Debus V; Socha P; Sykut-Cegielska J; van Spronsen F; de Meirleir L; Vajro P; DeClue T; Ficicioglu C; Wada Y; Wevers RA; Vanderschaeghe D; Callewaert N; Fingerhut R; van Schaftingen E; Freeze HH; Morava E; Lefeber DJ; Marquardt T
N Engl J Med; 2014 Feb; 370(6):533-42. PubMed ID: 24499211
[TBL] [Abstract][Full Text] [Related]
16. AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG).
Balakrishnan B; Altassan R; Budhraja R; Liou W; Lupo A; Bryant S; Mankouski A; Radenkovic S; Preston GJ; Pandey A; Boudina S; Kozicz T; Morava E; Lai K
Transl Res; 2023 Jul; 257():1-14. PubMed ID: 36709920
[TBL] [Abstract][Full Text] [Related]
17. Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency (PGM1-CDG).
Altassan R; Albert-Brotons DC; Alowain M; Al-Halees Z; Jaeken J; Morava E
JIMD Rep; 2023 Mar; 64(2):123-128. PubMed ID: 36873091
[TBL] [Abstract][Full Text] [Related]
18. Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects.
Morelle W; Potelle S; Witters P; Wong S; Climer L; Lupashin V; Matthijs G; Gadomski T; Jaeken J; Cassiman D; Morava E; Foulquier F
J Clin Endocrinol Metab; 2017 Apr; 102(4):1375-1386. PubMed ID: 28323990
[TBL] [Abstract][Full Text] [Related]
19. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
[TBL] [Abstract][Full Text] [Related]
20. Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency.
Wong SY; Beamer LJ; Gadomski T; Honzik T; Mohamed M; Wortmann SB; Brocke Holmefjord KS; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Ackermann A; Stanley CA; Rymen D; Zeharia A; Al-Sayed M; Marquardt T; Jaeken J; Lefeber D; Conrad DF; Kozicz T; Morava E
J Pediatr; 2016 Aug; 175():130-136.e8. PubMed ID: 27206562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
